Medical Devices
QMSR readiness is an evidence problem - not a checklist problem
How to convert procedural mapping into demonstrable control across the quality system.
Readiness cannot be established by a completed checklist alone. An organization must show that responsibilities, processes, records, decisions, and feedback loops operate as designed.
Move from clauses to process evidence
Map each applicable requirement to procedures, owners, training, records, metrics, exceptions, and management oversight. Then sample the evidence vertically across real products and horizontally across connected processes.
Test the interfaces
Many failures occur between systems: complaint to CAPA, risk management to design change, supplier controls to incoming acceptance, and post-market signal to regulatory reporting.
Prepare people as well as documents
Process owners should be able to explain the purpose of the control, how they execute it, what evidence remains, and how exceptions are escalated.
Current FDA requirements
FDA's QMSR became effective February 2, 2026. It incorporates ISO 13485:2016 by reference and includes FDA-specific requirements. Read the FDA QMSR FAQ and ISO 13485 overview when evaluating applicability.
Further regulatory context
Read medical device regulatory definitions and authoritative references. Explore the workflows eeRegOS supports.
Editorial note: This content is educational and does not constitute legal or regulatory advice. Product-specific decisions should be reviewed by qualified professionals using current authoritative sources.